Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cbbb49db66e7d9289b75bb837706b113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01a3dd9aa52b95ac62e00effc8acd096 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-252 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-624 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6935 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6939 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1887 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
filingDate |
2020-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa77be0a90dae80c847a5deef5b09561 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3a8c286afce1151cb3e3c5a50f4de06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b5423208b278705e7478b7506cf2012 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_183788805e670eee76c85b2aac8f4fd2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b28c0241e7026e76e96a77ec6dbbf14d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e57ead4c9e2e6e42cd57ca1c361e9f1f |
publicationDate |
2022-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2022119563-A1 |
titleOfInvention |
Composition and method for treatment of ischemic disease |
abstract |
The present application provides a composition and a method for treating ischemia disease. The composition for treatment of ischemia disease comprises an angiopeptide comprising an amino acid sequence shown as any of SEQ ID Nos: 1 to 3; and a carrier for carrying the angiopeptide. The carrier can be a nanoparticle, a hygrogel or a combination thereof. The method for treatment of ischemia disease comprises administering the composition to a subject. |
priorityDate |
2020-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |